ACCP collaborates with ASHP on Oncology Pharmacy activities.

• Overview
• Target Audience
• Faculty
• Learning Objectives
• CPE Credit
• Recertification Credit
• Hardware and Software Requirements
• Commercial Support

This webinar series is part of the professional development program for the recertification of the BCOP pharmacist.

This course is intended for BCOPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice.

This online activity is approved for 1.5 hours of continuing pharmacy education credit and/or recertification credit.

This webinar recording covers the most critical guideline updates from ASCO and NCCN, review the most critical publications of interest to BCOPs, and briefly highlight new drug indications and approvals since April 2020.

Release date: October 14, 2020
BCOP credit expiration date: October 12, 2021
ACPE credit expiration date: October 13, 2023

The target audience for Oncology Guideline, Drug, and Publication Update 2020 is the pharmacist interested in learning more about the most critical guidelines that have been released in 2020 or for Board-certified Oncology Pharmacists (BCOPs) looking to earn recertification credit.

Solid Tumor Cancers
	Renee K. McAlister, Pharm.D., BCOP Clinical Pharmacy Specialist, Melanoma/GU Oncology Vanderbilt University Medical Center Nashville, Tennessee
Blood Cancers
	Jessica J. Auten, Pharm.D., BCPS, BCOP Clinical Pharmacy Specialist, Malignant Hematology Director, PGY2 Oncology Pharmacy Residency University of North Carolina Medical Center Assistant Professor of Clinical Education UNC Eshelman School of Pharmacy Chapel Hill, North Carolina

Conflict of Interest Disclosures

At the conclusion of the program participants should be able to:

1. Review newly approved oncologic agents and treatment regimens for patients with solid tumors.
2. Evaluate literature associated with new approvals.
3. Describe changes to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines for various solid tumor diagnoses.
4. Discuss incorporation of updates into clinical practice.
5. Identify FDA-approvals of novel and existing therapies in the treatment of acute leukemias and myelodysplastic syndromes, chronic leukemias, lymphoma, and multiple myeloma.
6. Evaluate clinical data supporting recent FDA-approvals in hematologic malignancies.
7. Design an appropriate patient-specific treatment, supportive care, and monitoring plan taking into consideration efficacy and safety outcomes from clinical trials and current guidelines for patients with hematologic malignancies as it relates to newly approved therapies.

The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The Oncology Guideline, Drug, and Publication Update 2020 Webinar will provide one session with 1.5 contact hours of continuing pharmacy education credit and/or 1.5 hours of BCOP recertification credit. The Universal Activity Number for this webinar is:

0217-9999-20-179-H01-P
1.5 contact hours
Application-based activity

To be eligible to earn continuing pharmacy education credit, participants must purchase the Oncology Guideline, Drug, and Publication Update 2020 Webinar, and successfully review all content and complete, submit and pass the Web-based posttest by October 13, 2023. Posttests may not be submitted more than one time. Partial credit is not available for this activity.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

To be eligible to earn BCOP recertification credit, participants must purchase the Oncology Guideline, Drug, and Publication Update 2020 Webinar, successfully review the recordings, and complete, submit and pass a Web-based posttest by October 12, 2021. The passing point to earn BCOP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCOP posttest deadline that meets this passing point will earn BCOP recertification credits. These credits will be assigned as of the date of test submission. Posttests may not be submitted more than one time. Partial credit is not available for this activity. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCOP recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org.

To access the webinar recording by a computer, you will need broadband Internet access, an updated Internet browser, Adobe Flash Player, and speakers or headphones for audio. To access the webinars on a Wi-Fi enabled mobile device, you will need a wireless internet connection and the Adobe Connect App, a free app which can be downloaded from Apple’s App Store or Google Play. Participants who experience difficulty in accessing a webinar should contact ACCP by e-mail at [email protected] or by phone at (913) 492-3311.

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.